News
Xeljanz/Xeljanz XR Approved for Active Ankylosing Spondylitis
The approval was based on data from a phase 3 study which evaluated tofacitinib in adults with active AS who had an inadequate response to at least 2 NSAIDs.
Your search for tofacitinib returned 27 results
News
Tofacitinib Improves Rheumatoid Arthritis Treatment Response
The addition of tofacitinib to rheumatoid arthritis (RA) treatment regimens improves patient response to non-biologic disease-modifying antirheumatic drugs (DMARDs).
News
Tofacitinib Superior to Placebo for Rheumatoid Arthritis
For patients with rheumatoid arthritis, a novel oral Janus kinase inhibitor, tofacitinib, is associated with reduced symptoms when used as monotherapy or in addition to background methotrexate.
News
Tofacitinib Effective for Moderate-to-Severe Ulcerative Colitis
A total of 18.5% patients taking tofacitinib experienced a remission of their condition in 8 weeks compared to just 8.2% of patients receiving placebo.
Drug News
Tofacitinib vs. Methotrexate for Rheumatoid Arthritis
Tofacitinib is superior to methotrexate in treating rheumatoid arthritis, but increased side effects were seen with tofacitinib, including development of herpes zoster.
News
Tofacitinib Assessed for Efficacy in Nail Psoriasis
The researchers found that significantly more patients receiving tofacitinib 5mg and tofacitinib 10mg versus placebo achieved a ≥50% reduction in the Nail Psoriasis Severity Index (NAPSI) score from baseline (NAPSI50)
News
Tofacitinib Slows Joint Damage in Rheumatoid Arthritis
Tofacitinib slows the progression of joint damage and improves disease activity in patients with rheumatoid arthritis (RA).
News
Tofacitinib Efficacy Investigated in Patients With Psoriatic Arthritis
Tofacitinib is superior for patients with inadequate response to TNF inhibitors or conventional DMARDs
News
Tofacitinib Benefits Patients With Active Ulcerative Colitis
Tofacitinib, an oral inhibitor of Janus kinase 1, 2, and 3, can reduce disease severity and induce remission better than a placebo in patients with moderately to severely active ulcerative colitis.
News
Rheumatoid Arthritis Tx Shows Promise for Hair Regrowth in Alopecia
A drug used for rheumatoid arthritis might regrow hair in alopecia areata (AA) patients, according to a study published online September 22 in JCI Insight.
